You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Details for New Drug Application (NDA): 021247


✉ Email this page to a colleague

« Back to Dashboard


NDA 021247 describes AEROSPAN HFA, which is a drug marketed by Mylan Speciality Lp and is included in one NDA. Additional details are available on the AEROSPAN HFA profile page.

The generic ingredient in AEROSPAN HFA is flunisolide. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the flunisolide profile page.
Summary for 021247
Tradename:AEROSPAN HFA
Applicant:Mylan Speciality Lp
Ingredient:flunisolide
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL, METERED;INHALATIONStrength0.078MG/INH
Approval Date:Jan 27, 2006TE:RLD:Yes

Expired US Patents for NDA 021247

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp AEROSPAN HFA flunisolide AEROSOL, METERED;INHALATION 021247-001 Jan 27, 2006 ⤷  Try a Trial ⤷  Try a Trial
Mylan Speciality Lp AEROSPAN HFA flunisolide AEROSOL, METERED;INHALATION 021247-001 Jan 27, 2006 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.